Europe — EMA
Oxigén Linde (Oxygen)
Oxygen, the active ingredient in Oxigén Linde, is a medical gas presented as a inhalation gas for respiratory support use. It provides supplemental oxygen to patients who require enhanced oxygenation due to respiratory…
Request sourcing
What is Oxygen?
Oxygen, the active ingredient in Oxigén Linde, is a medical gas presented as a inhalation gas for respiratory support use. It provides supplemental oxygen to patients who require enhanced oxygenation due to respiratory compromise, acute illness, or peri‑operative care. GNH USA supplies Oxigén Linde as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.
GNH USA supplies Oxigén Linde as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.
What is Oxygen used for?
Oxigén Linde is used in respiratory support and oxygen therapy pathways, delivering supplemental oxygen to improve tissue oxygenation. - Acute hypoxemia: restores normal oxygen saturation in patients with sudden low blood‑oxygen levels. - Chronic obstructive pulmonary disease (COPD): helps maintain adequate oxygen levels during daily activities and sleep. - Peri‑operative care: supports oxygenation before, during and after surgery. - High‑altitude exposure: prevents hypoxia in individuals exposed to low‑pressure environments. - Carbon‑carbon
What are the side effects of Oxygen?
Oxygen therapy can be associated with a range of reactions, from mild irritation to serious complications.
Common Side Effects: - Nasal dryness or irritation: mild discomfort in the nasal passages. - Headache: transient headache related to changes in oxygen levels. - Cough: irritation of the airway causing a cough. - Fatigue: feeling of tiredness after prolonged use.
Serious or Rare Side Effects: - Pulmonary oxygen toxicity: lung injury from prolonged high‑concentration exposure. - Fire‑hazard -
What precautions apply to Oxygen?
Oxygen ... … ... ... … … …



